« Back to Record
Modi, S., Jacot, W., Iwata, H., Park, Y. H., Vidal, M. J. M., Li, W., Tsurutani, J., Ueno, N. T., Zaman, K., Prat, A., Papazisis, K., Rugo, H. H., Yamashita, T., Harbeck, N., Im, S. –., De Laurentiis, M., Pierga, J. Y. V. J., Wang, X., Gombos, A., Tokunaga, E., Orbegoso Aguilar, C., Yung, L., Xiao, F., Cheng, Y., & Cameron, D. A. (2025). Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial. Nature medicine, 31(12), 4205-4213. doi:10.1038/s41591-025-03981-4
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/405023



